Flowchart of the MCL cohorts. The 38 patients from Uppsala also contributed with 29 samples taken during treatment, 33 samples taken in remission, and 6 samples taken at later relapses. Twenty-four of the patients from Uppsala had matching tissue samples from the time of diagnosis (n = 21) or relapse (n = 3).